OS Therapies Inc (OSTX) shareholders
Close on Nov 17, 2026Market cap $34.35MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 5,434,150 | 9.90% | 13G (passive) amendment | Sep 30, 2026 |
| Shalom Auerbach Joint filing with Einodmil LLC (8.40%) | 2,677,570 | 8.50% | 13D (active) amendment | Jul 29, 2025 |
| Ayala Pharmaceuticals, Inc. | 2,164,215 | 9.99% | 13G (passive) | Apr 9, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of OSTX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 777,651 | 1.69% | $1.48M | +308,184 | 0.00% |
| CM Management, LLC | 400,000 | 0.87% | $760.00K | – | 0.51% |
| Geode Capital Management, LLC | 301,794 | 0.65% | $573.41K | +21,749 | 0.00% |
| Howard Financial Services, Ltd. | 248,001 | 0.54% | $471.20K | +2,565 | 0.05% |
| BlackRock, Inc. | 242,479 | 0.53% | $460.71K | +177,707 | 0.00% |
| Vanguard Fiduciary Trust Co | 174,132 | 0.38% | $330.85K | +57,469 | 0.00% |
| State Street Corp | 120,100 | 0.26% | $228.19K | +28,900 | 0.00% |
| Marshall Wace, Llp | 100,640 | 0.22% | $191.22K | New | 0.00% |
| HighTower Advisors, LLC | 85,550 | 0.19% | $162.55K | +70,350 | 0.00% |
| Northern Trust Corp | 70,817 | 0.15% | $134.55K | +4,763 | 0.00% |
| Beacon Pointe Advisors, LLC | 62,507 | 0.14% | $118.76K | – | 0.00% |
| Bridgeway Capital Management, LLC | 45,000 | 0.10% | $85.50K | +20,000 | 0.00% |
| Ingalls & Snyder LLC | 36,676 | 0.08% | $70.00K | – | 0.00% |
| Two Sigma Investments, LP | 30,414 | 0.07% | $57.79K | +4,034 | 0.00% |
| Stifel Financial Corp | 27,900 | 0.06% | $53.01K | +12,900 | 0.00% |
| Jane Street Group, LLC | 26,999 | 0.06% | $51.30K | −13,317 | 0.00% |
| Axq Capital, LP | 24,623 | 0.05% | $46.78K | New | 0.01% |
| Vanguard Global Advisers, LLC | 20,958 | 0.05% | $39.82K | – | 0.00% |
| Stratos Wealth Advisors, LLC | 19,314 | 0.04% | $36.70K | +5,497 | 0.00% |
| Quadrature Capital Ltd | 15,662 | 0.03% | $29.76K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 29 | 3M | 6.3% | 6 / 15 | 3 / 6 | 1M | 1M |
| Q1 2026 | 29 | 3M | 6.3% | 11 / 8 | 2 / 6 | 2M | 0M |
| Q4 2025 | 25 | 2M | 3.8% | 7 / 8 | 4 / 6 | 1M | 0M |
| Q3 2025 | 25 | 2M | 3.4% | 13 / 5 | 2 / 1 | 1M | 0M |
| Q2 2025 | 13 | 1M | 1.3% | 7 / 2 | 1 / 0 | 0M | 0M |
| Q1 2025 | 6 | 0M | 0.8% | 2 / 2 | 1 / 1 | 0M | 0M |
| Q4 2024 | 5 | 0M | 0.3% | 2 / 1 | 1 / 4 | 0M | 0M |
| Q3 2024 | 7 | 0M | 0.3% | 7 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
9 funds held OSTX in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of OSTX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 416,115 | 0.90% | $790.62K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 361,536 | 0.78% | $686.92K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 145,135 | 0.31% | $310.59K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 110,432 | 0.24% | $209.82K | 0.01% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 45,000 | 0.10% | $85.50K | 0.06% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 34,884 | 0.08% | $74.65K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 32,844 | 0.07% | $70.29K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 7,436 | 0.02% | $14.13K | 0.01% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -1,800 | -0.00% | -$3.42K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul A. Romness | President and CEO, Director | 2,473,000 | 5.36% | Oct 30, 2026 |
| Kerry M. Clem | Chief Commercial Officer | 225,000 | 0.49% | Nov 12, 2026 |
| Knuettel Francis II | Chief Financial Officer | 270,000 | 0.59% | Nov 12, 2026 |
| Robert Petit | See Remarks | 200,000 | 0.43% | Oct 30, 2026 |
| Christopher P. Acevedo | Chief Financial Officer | 109,375 | 0.24% | Feb 13, 2026 |
| Craig Eagle | Director | – | – | Oct 30, 2026 |
| Olivier Roger Jarry | Director | – | – | Oct 30, 2026 |
| Theodore F. Search | Director | 455,835 | 0.99% | Oct 30, 2026 |
| John Ciccio | Director | 455,835 | 0.99% | Oct 30, 2026 |
| Avril Suzette McKean-Dieser | Director | 5,000 | 0.01% | Oct 30, 2026 |
| Karim Galzahr | Director | – | – | Feb 13, 2026 |
| Colin Goddard | Director | 225,179 | 0.49% | Feb 14, 2025 |
| LLC Einodmil | – | 2,829,582 | 6.13% | May 9, 2025 |
| Shalom Auerbach | – | 2,687,570 | 5.83% | May 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Knuettel Francis II Chief Financial Officer | Nov 10, 2026 | Award | +250,000 | – | – | 250,000 |
| Kerry M. Clem Chief Commercial Officer | Nov 10, 2026 | Award | +200,000 | – | – | 225,000 |
| Shalom Auerbach 10% owner | May 7, 2025 | Sale | −82,000 | $2.00 | $164.00K | 2,664,199 |
| Shalom Auerbach 10% owner | Apr 10, 2025 | Sale | −10,000 | $1.39 | $13.90K | 2,746,199 |
| Shalom Auerbach 10% owner | Apr 9, 2025 | Sale | −50,012 | $1.35 | $67.52K | 2,756,199 |
| Paul A. Romness President and CEO, Director, 10% owner | Feb 28, 2025 | Other | +225,000 | – | – | 2,473,000 |
| LLC Einodmil 10% owner | Feb 27, 2025 | Other | −225,000 | $1.64 | $369.00K | 2,806,211 |
| LLC Einodmil 10% owner | Feb 14, 2025 | Sale | −100,000 | $2.84 | $284.00K | 2,431,211 |
| Shalom Auerbach 10% owner | Jan 15, 2025 | Sale | −16,720 | $6.74 | $112.69K | 2,531,211 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +270,465 | – | – | 1,736,306 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +23,371 | – | – | 23,371 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +633,980 | – | – | 1,438,355 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +27,486 | – | – | 1,465,841 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +53,468 | – | – | 1,789,774 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +131,472 | – | – | 1,921,246 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +78,710 | – | – | 1,999,956 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +88,940 | – | – | 2,088,896 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +179,027 | – | – | 2,267,923 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +51,035 | – | – | 2,318,958 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +178,135 | – | – | 2,497,093 |
| Shalom Auerbach 10% owner | Aug 2, 2024 | Conversion | +50,838 | – | – | 2,547,931 |
| John Ciccio Director | Aug 2, 2024 | Conversion | +30,264 | – | – | 435,835 |
| John Ciccio Director | Aug 2, 2024 | Conversion | +101,765 | – | – | 139,265 |
| John Ciccio Director | Aug 2, 2024 | Conversion | +266,306 | – | – | 405,571 |
| Theodore F. Search Director | Aug 2, 2024 | Conversion | +30,264 | – | – | 435,835 |
| Theodore F. Search Director | Aug 2, 2024 | Conversion | +101,765 | – | – | 139,265 |
| Theodore F. Search Director | Aug 2, 2024 | Conversion | +266,306 | – | – | 405,571 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of OS Therapies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 14,528 shares on Sep 18, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| LLC Einodmil 10% stockholder | May 7, 2025 | 1,200,000 | $2.81M | May 7, 2025 | Shares of common stock of the Issuer that were issued upon the automatic conversion of convertible promissory notes held by Einodmil LLC, which occurred upon the consummation of the Issuer's initial p |
See a number that looks wrong?